Authors: Huijbregts, SCJ de Sonneville, LMJ Licht, R van Spronsen, FJ Verkerk, PH Sergeant, JA

Citation: Scj. Huijbregts et al., Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations, NEUROPSYCHO, 40(1), 2002, pp. 7-15

Authors: Van der Kamp, HJ Noordam, K Elvers, B Van Baarle, M Otten, BJ Verkerk, PH

Citation: Hj. Van Der Kamp et al., Newborn screening for congenital adrenal hyperplasia in the Netherlands, PEDIATRICS, 108(6), 2001, pp. 1320-1324

Authors: Boshuizen, HC van der Lem, GJ Kauffman-de Boer, MA van Zanten, GA Oudesluys-Murphy, AM Verkerk, PH

Citation: Hc. Boshuizen et al., Costs of different strategies for neonatal hearing screening: a modelling approach, ARCH DIS CH, 85(3), 2001, pp. F177-F181

Authors: Stemerdink, BA Kalverboer, AF van der Meere, JJ van der Molen, MW Huisman, J de Jong, LWA Slijper, FME Verkerk, PH van Spronsen, FJ

Citation: Ba. Stemerdink et al., Behaviour and school achievement in patients with early and continuously treated phenylketonuria, J INH MET D, 23(6), 2000, pp. 548-562

Authors: Bongers-Schokking, JJ Koot, HM Wiersma, D Verkerk, PH Keizer-Schrama, SMPFD

Citation: Jj. Bongers-schokking et al., Influence of timing and dose of thyroid hormone replacement on developmentin infants with congenital hypothyroidism, J PEDIAT, 136(3), 2000, pp. 292-297

Authors: Stemerdink, NBA van der Molen, MW Kalverboer, AF van der Meere, JJ Huisman, J de Jong, LW Slijper, FME Verkerk, PH van Spronsen, FJ

Citation: Nba. Stemerdink et al., Prefrontal dysfunction in early and continuously treated phenylketonuria, DEV NEUROPS, 16(1), 1999, pp. 29-57